C12N 2840/55
From bacteria
Official title: from bacteria
C12N2840/55 (From bacteria) appears on 25 US grants and 30 published applications in this corpus.
Search patents in C12N- Granted patents
- 25
- Published applications
- 30
- Assignees
- 15
- Inventors
- 40
- Latest grant
- 10 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 3 |
| 2003 | 4 | 1 |
| 2004 | 3 | 2 |
| 2005 | 0 | 1 |
| 2006 | 2 | 0 |
| 2007 | 1 | 1 |
| 2008 | 1 | 0 |
| 2009 | 0 | 2 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 2 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 1 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 2 |
| 2020 | 1 | 2 |
| 2021 | 1 | 5 |
| 2022 | 4 | 1 |
| 2023 | 1 | 2 |
| 2024 | 4 | 2 |
| 2025 | 1 | 1 |
| 2026 | 1 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Circular RNA for translation in eukaryotic cells10 Mar 2026US 12,570,996 B2Massachusetts Institute of Technology
- Circular RNA for translation in eukaryotic cells30 Dec 2025US 12,509,701 B2Massachusetts Institute of Technology
- Methods and compositions to prevent microbial infection10 Dec 2024US 12,163,135 B2BioPlx, Inc.
- Gene expression cassette capable of initiating translation after completion of transcription for producing high-quality recombinant protein in bacteria12 Nov 2024US 12,139,715 B2Seoul National University R&Db Foundation
- Viral vector production system6 Aug 2024US 12,054,735 B2Oxford Biomedica (UK) Limited
- Circular RNA For Translation In Eukaryotic Cells30 Apr 2026US 2026/0117252 A1Massachusetts Institute of Technology
- Circular RNA For Translation In Eukaryotic Cells19 Mar 2026US 2026/0078400 A1Massachusetts Institute of Technology
- Methods and compositions to prevent microbial infection13 Nov 2025US 2025/0346910 A1Commense Bio, Inc.
- Circular RNA For Translation In Eukaryotic Cells15 Aug 2024US 2024/0271158 A1Massachusetts Institute of Technology
- Circular RNA For Translation In Eukaryotic Cells16 May 2024US 2024/0158807 A1Massachusetts Institute of Technology
Most cited
By later US patents
- Method for selective inactivation of viral replication40US 6,667,152 B2Rigel Pharmaceuticals, Inc. · 2003
- Reagents and methods useful for controlling the translation of hepatitis GBV proteins37US 5,955,318 AAbbott Laboratories · 1999
- Circular RNA for translation in eukaryotic cells16US 11,203,767 B2Massachusetts Institute of Technology · 2021
- Method for selective inactivation of viral replication13US 6,623,961 B2Rigel Pharmaceuticals, Inc. · 2003
- Method for selective inactivation of viral replication13US 6,777,179 B2Rigel Pharmaceuticals, Inc. · 2004